Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
M. Vree. (2002) Lower hormone dosage with improved cycle control. The European Journal of Contraception & Reproductive Health Care 7:sup2, pages 25-30.
Read now
Read now
F. Roumen. (2002) Contraceptive efficacy and tolerability with a novel combined contraceptive vaginal ring, NuvaRing. The European Journal of Contraception & Reproductive Health Care 7:sup2, pages 19-24.
Read now
Read now
Linda S Kahn & Uriel Halbreich. (2001) Oral contraceptives and mood. Expert Opinion on Pharmacotherapy 2:9, pages 1367-1382.
Read now
Read now
H. Ferguson, M. L. Vree, J. Wilpshaar & T. K. A. B. Eskes. (2000) Multicenter study of the efficacy, cycle control and tolerability of a phasic desogestrel-containing oral contraceptive. The European Journal of Contraception & Reproductive Health Care 5:1, pages 35-45.
Read now
Read now
Articles from other publishers (25)
Jeppe B Schroll, Amanda Y Black, Cindy Farquhar & Innie Chen. (2023) Combined oral contraceptive pill for primary dysmenorrhoea. Cochrane Database of Systematic Reviews 2023:7.
Crossref
Crossref
S O Dubrovina. (2018) Topical issues in combined oral contraceptives usage. Gynecology 20:2, pages 60-63.
Crossref
Crossref
Purvita Dam, Joydip Paul, Indranil Banerjee, Ashima Sorkhel & Partha Sarathi Chakravorty. (2015) TO STUDY THE ACCEPTABILITY AND EFFICACY OF COMBINED CONTRACEPTIVE VAGINAL RING AMIDST INDIAN WOMEN. Journal of Evolution of Medical and Dental Sciences 4:38, pages 6602-6612.
Crossref
Crossref
Maria F Gallo, Laureen M Lopez, David A Grimes, Florence Carayon, Kenneth F Schulz & Frans M Helmerhorst. (2014) Combination contraceptives: effects on weight. Cochrane Database of Systematic Reviews 2014:1.
Crossref
Crossref
Theresa A Lawrie, Frans M Helmerhorst, Nandita K. Maitra, Regina Kulier, Kitty Bloemenkamp & A Metin Gülmezoglu. (2011) Types of progestogens in combined oral contraception: effectiveness and side-effects. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Maria F Gallo, Kavita Nanda, David A Grimes, Laureen M Lopez & Kenneth F Schulz. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Cosima Brucker, Bernard Hedon, Hok Sien The, Kornelia Höschen, Natascha Binder & Annette Christoph. (2010) Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen. Contraception 81:6, pages 501-509.
Crossref
Crossref
Olivier Graesslin, Philippe Barjot, Médéric Hoffet, Daniel Cohen, Philippe Vaillant & Pierre Clerson. (2009) The EVAPIL® scale, a new tool to assess tolerance of oral contraceptives. Contraception 80:6, pages 540-554.
Crossref
Crossref
Chooi L Wong, Cindy Farquhar, Helen Roberts & Michelle Proctor. (2009) Oral contraceptive pill for primary dysmenorrhoea. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Chooi L Wong, Cindy Farquhar, Helen Roberts & Michelle Proctor. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Rossella E. Nappi, Silvia Tonani, Valentina Santamaria, Alessandra Ornati, Francesca Albani, Carla Pisani & Franco Polatti. (2009) Disturbo disforico della fase luteale e sindrome premestruale. Quaderni Italiani di Psichiatria 28:1, pages 27-33.
Crossref
Crossref
Maria F Gallo, Kavita Nanda, David A Grimes, Laureen M Lopez & Kenneth F Schulz. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Alison B. Edelman, Stephanie L. Koontz, Mark D. Nichols & Jeffrey T. Jensen. (2006) Continuous Oral Contraceptives. Obstetrics & Gynecology 107:3, pages 657-665.
Crossref
Crossref
Maria F Gallo, Laureen M Lopez, David A Grimes, Kenneth F Schulz & Frans M Helmerhorst. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Virginia J. Vitzthum & Karin Ringheim. (2005) Hormonal Contraception and Physiology: A Research‐based Theory of Discontinuation Due to Side Effects. Studies in Family Planning 36:1, pages 13-32.
Crossref
Crossref
Regina Kulier, Frans M Helmerhorst, Nandita Maitra & A Metin Gülmezoglu. (2004) Effectiveness and acceptability of progestogens in combined oral contraceptives – a systematic review. Reproductive Health 1:1.
Crossref
Crossref
Nandita N Maitra, Regina Kulier, Kitty Bloemenkamp, Frans M Helmerhorst & A Metin Gülmezoglu. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Maria F. Gallo, David A. Grimes, Kenneth F. Schulz & Frans M. Helmerhorst. (2004) Combination Estrogen–Progestin Contraceptives and Body Weight: Systematic Review of Randomized Controlled Trials. Obstetrics & Gynecology 103:2, pages 359-373.
Crossref
Crossref
J Callejo, J Díaz, A Ruiz & R.M García. (2003) Effect of a low-dose oral contraceptive containing 20 μg ethinylestradiol and 150 μg desogestrel on dysmenorrhea. Contraception 68:3, pages 183-188.
Crossref
Crossref
S. Taneepanichskul, R. Kriengsinyot & U. Jaisamrarn. (2002) A comparison of cycle control, efficacy, and side effects among healthy Thai women between two low-dose oral contraceptives containing 20 μg ethinylestradio1/75 μg gestodene (Meliane) and 30 μg ethinylestradio1/75 μg gestodene (Gynera®). Contraception 66:6, pages 407-409.
Crossref
Crossref
Patou Tantbirojn & Surasak Taneepanichskul. (2002) Clinical comparative study of oral contraceptives containing 30 μg ethinylestradiol/150 μg levonorgestrel, and 35 μg ethinylestradiol/250 μg norgestimate in Thai women. Contraception 66:6, pages 401-405.
Crossref
Crossref
Ellen W. FreemanRobin KrollAndrea RapkinTeri PearlsteinCandace BrownKelly ParseyPaul ZhangHarji PatelMarie Foegh. (2001) Evaluation of a Unique Oral Contraceptive in the Treatment of Premenstrual Dysphoric Disorder. Journal of Women's Health & Gender-Based Medicine 10:6, pages 561-569.
Crossref
Crossref
F.J.M.E. Roumen, D. Apter, T.M.T. Mulders & T.O.M. Dieben. (2001) Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Human Reproduction 16:3, pages 469-475.
Crossref
Crossref
Alfred Poindexter. (2001) The emerging use of the 20-μg oral contraceptive. Fertility and Sterility 75:3, pages 457-465.
Crossref
Crossref
Roger J. Garceau, Charles J. Wajszczuk & Andrew M. Kaunitz. (2000) Bleeding patterns of women using Lunelle™ monthly contraceptive injections (medroxyprogesterone acetate and estradiol cypionate injectable suspension) compared with those of women using Ortho-Novum® 7/7/7 (norethindrone/ethinyl estradiol triphasic) or other oral contraceptives. Contraception 62:6, pages 289-295.
Crossref
Crossref